Blogs

Melanoma therapy costs could be slashed thanks to new device, says OncoSec

On April 23, 2012, in Blogs, by admin
0

in-Pharma Technologist, October 6, 2011 The price of melanoma therapy could soon be slashed thanks to a new delivery system developed by US firm OncoSec. Link

EMCC: Personalized Medicine May Prove Faster and More Effective

On April 23, 2012, in Blogs, by admin
0

Cancer Network, September 30, 2011 This article discusses the issues surrounding clinical trial research design for ‘personalized medicine focusing on patient subpopulations‘. Link

EMCC: Veliparib Plus Temozolomide in Metastatic Melanoma Trends Toward Increased PFS but Results Are Not Statistically Significant

On April 23, 2012, in Blogs, by admin
0

Cancer Network, September 30, 2011 This provides results of a clinical trial of veliparib combined with temozolomide(TMZ) in treating Stage III – Stage IV metastatic melanoma. The study reports ‘nearly doubled the numerical median progression-free survival (PFS) compared to TMZ alone, but that these differences were not statistically significant.’ The trial enrolled 346 patients to [...]

« Previous Entries